Is there a role for total neoadjuvant treatment in early-stage rectal cancer?
Selective utilization of TNT in S1RC holds the potential to foster organ preservation, particularly for low rectal cancer. Larger prospective studies with longer follow-up and standardized treatment protocols are needed to validate these preliminary findings.
Authors
- Jacob A. Miller (ORCID: https://orcid.org/0000-0002-8480-5492)
- Kamil Erözkan (ORCID: https://orcid.org/0000-0003-2193-9984)
- Scott Steele
- Emre Görgün (ORCID: https://orcid.org/0000-0001-7725-3522)
- Hermann Keßler
- David Liska (ORCID: https://orcid.org/0000-0002-8632-6065)
- Metincan Erkaya (ORCID: https://orcid.org/0000-0002-4707-6059)
- Ali Alipouriani (ORCID: https://orcid.org/0000-0002-0438-3251)
Institutions
- Cleveland Clinic (US)
- Ege University (TR)
Publication Details
- Journal
- Langenbeck s Archives of Surgery
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1007/s00423-025-03895-2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ege Üniversitesi